Assessing the benefits of digital adherence monitoring for sites and patients.
Bernard Vrijens
Advertisement
CEO & Scientific Lead, AARDEX Group
Articles by Bernard Vrijens
A look at some of the leading causes of study failure and explain how improving medication adherence could be the key to risk mitigation.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
2
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
3
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
4
Addressing Preclinical Gaps to Prevent Biotech Trial Delays
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
